Annina Seiler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Annina Seiler has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
David Blum
University of Zurich, Zurich, Switzerland
8 shared publicationsCaroline Hertler
Klinik für Radio-Onkologie, Kompetenzzentrum Palliative Care, Universitätsspital Zürich und Universität Zürich, Zürich, Schweiz
6 shared publications- Josef Jenewein
Department of Medical Psychology and Psychotherapy, Medical University of Graz, Graz, Austria
6 shared publications Christopher P. Fagundes
Department of Psychology, Rice University, Houston, TX, United States; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
5 shared publicationsMarkus Schettle
Klinik für Radio-Onkologie, Kompetenzzentrum Palliative Care, Universitätsspital Zürich und Universität Zürich
5 shared publicationsRoland von Känel
5 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-14
Narrative identity at the end of life: a qualitative analysis of dignity therapy interviews from an existential perspective
Confronting terminal illness and the prospect of death and dying can severely undermine an individual’s sense of identity, meaning and purpose in life, leading to existential suffering, increasing hopelessness, depressive symptoms, and death anxieties. This study explored how narrative approaches can alleviate existential suffering, promote emotional healing, and consolidate identity for individuals confronted with death and dying. Specifically, the study aimed to (1) analyze dimensions of identity reflected in Dignity Therapy (DT) legacy documents from a randomized controlled trial, applying Ricoeur’s framework of selfhood and identity; (2) deepen the understanding of existential suffering in relation to identity and its potential transformation into meaningful adaptation; and (3) synthesize these findings into a conceptual Model of Narrative Identity at the End of Life. Thirty-two DT interviews were analyzed using MAXQDA software for qualitative data analysis. An inductive category development approach was employed to construct a three-tiered coding system capturing key dimensions of identity. Drawing on Ricoeur’s framework of selfhood and identity, a hermeneutic and existential-phenomenological approach was employed to deepen understanding of the lived experiences and narrative reconstruction of self and identity in the context of vulnerability, suffering, loss, and the approaching end of life. The identified dimensions of narrative identity included “origin”, “family”, “movement”, “societal”, “work”, “recreation”, “disruption”, “experience of the now”, “feelings”, “sense of self”, and “future”. Analysis of patients’ narratives yielded an in-depth understanding of existential suffering, as well as the contrasting experiences of authenticity, integrity, and wholeness at the end of life. Three core mechanisms emerged through which narrative work may mitigate existential suffering while reaffirming selfhood and identity: (1) cultivation healing connections and embracing hope; (2) the search for coherence and meaning-making; and (3) inner growth and transformation. These findings informed the development of a conceptual Model of Narrative Identity at the End of Life. Confronting death and dying is challenging, yet it may serve as a catalyst for increased self-awareness, self-growth, and transformation towards greater authenticity. Storytelling is a simple yet powerful tool for reclaiming narrative identity and alleviating existential suffering during a time marked by loss of control and powerlessness. Our Model of Narrative Identity at the End of Life illustrates how narrative work facilitates depth work, through which healing connections and hope can be embraced, enabling meaning-based adaptation to terminal illness, thereby empowering individuals to retain a sense of control, agency, and autonomy, even in the face of their own mortality. This study was registered with Clinical Trial Registry (ClinicalTrials.gov – Protocol Record NCT02646527; date of registration: 04/01/2016).
- 23 October 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-14
Open AccessNarrative identity at the end of life: a qualitative analysis of dignity therapy interviews from an existential perspective
Confronting terminal illness and the prospect of death and dying can severely undermine an individual’s sense of identity, meaning and purpose in life, leading to existential suffering, increasing hopelessness, depressive symptoms, and death anxieties. This study explored how narrative approaches can alleviate existential suffering, promote emotional healing, and consolidate identity for individuals confronted with death and dying. Specifically, the study aimed to (1) analyze dimensions of identity reflected in Dignity Therapy (DT) legacy documents from a randomized controlled trial, applying Ricoeur’s framework of selfhood and identity; (2) deepen the understanding of existential suffering in relation to identity and its potential transformation into meaningful adaptation; and (3) synthesize these findings into a conceptual Model of Narrative Identity at the End of Life. Thirty-two DT interviews were analyzed using MAXQDA software for qualitative data analysis. An inductive category development approach was employed to construct a three-tiered coding system capturing key dimensions of identity. Drawing on Ricoeur’s framework of selfhood and identity, a hermeneutic and existential-phenomenological approach was employed to deepen understanding of the lived experiences and narrative reconstruction of self and identity in the context of vulnerability, suffering, loss, and the approaching end of life. The identified dimensions of narrative identity included “origin”, “family”, “movement”, “societal”, “work”, “recreation”, “disruption”, “experience of the now”, “feelings”, “sense of self”, and “future”. Analysis of patients’ narratives yielded an in-depth understanding of existential suffering, as well as the contrasting experiences of authenticity, integrity, and wholeness at the end of life. Three core mechanisms emerged through which narrative work may mitigate existential suffering while reaffirming selfhood and identity: (1) cultivation healing connections and embracing hope; (2) the search for coherence and meaning-making; and (3) inner growth and transformation. These findings informed the development of a conceptual Model of Narrative Identity at the End of Life. Confronting death and dying is challenging, yet it may serve as a catalyst for increased self-awareness, self-growth, and transformation towards greater authenticity. Storytelling is a simple yet powerful tool for reclaiming narrative identity and alleviating existential suffering during a time marked by loss of control and powerlessness. Our Model of Narrative Identity at the End of Life illustrates how narrative work facilitates depth work, through which healing connections and hope can be embraced, enabling meaning-based adaptation to terminal illness, thereby empowering individuals to retain a sense of control, agency, and autonomy, even in the face of their own mortality. This study was registered with Clinical Trial Registry (ClinicalTrials.gov – Protocol Record NCT02646527; date of registration: 04/01/2016).
- Open Access
- 23 August 2024
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 67 (10) , 1144-1151
Einsamkeit am Lebensende
Zusammenfassung: Fortgeschrittene unheilbare Erkrankungen gehen aufgrund des zunehmenden Krankheitsprogresses mit zahlreichen Verlusten und Belastungen einher, welche die Autonomie und Selbstbestimmung sowie das Würdegefühl der Betroffenen erheblich beeinträchtigen und Einsamkeitsgefühle fördern können. Der gesundheitliche Abbau, die zunehmende Symptomlast, der Verlust von sozialen Rollen sowie die Angst vor dem Tod und dem Sterben zählen zu den wichtigsten Risikofaktoren für Einsamkeit am Lebensende. Dieser Artikel bietet einen Überblick über die verschiedenen Dimensionen der Einsamkeit am Lebensende. Die existentielle Einsamkeit wird in Abgrenzung zur emotionalen und sozialen Einsamkeit am Lebensende beleuchtet, Ursachen und gesundheitliche Auswirkungen von Einsamkeit am Lebensende werden diskutiert, auf diagnostische Instrumente wird hingewiesen und Empfehlungen zum Umgang mit der emotionalen, sozialen und existentiellen Einsamkeit am Lebensende werden ausgesprochen. Auch die Einsamkeit pflegender Angehöriger wird thematisiert. Im Artikel weisen wir darauf hin, wie wichtig es ist, der emotionalen und sozialen Einsamkeit am Lebensende frühzeitig entgegenzuwirken. Palliative, psychologische und spirituelle Unterstützung können dabei helfen, zwischenmenschliche Beziehungen zu stärken, Sinn und Bedeutung zu fördern und die negativen Auswirkungen von Einsamkeitsgefühlen auf die Gesundheit und die Lebensqualität zu reduzieren. Im Gegensatz dazu wird die existentielle Einsamkeit als Ausdruck hoher emotionaler Reife betrachtet und kann als entwicklungsfördernde Erfahrung zu einer besseren Verortung des Selbst sowie zur Stärkung von Identität, Würde und Transzendenz am Lebensende beitragen.
- 23 August 2024
- Published by Springer Nature in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
- Vol. 67 (10) , 1144-1151
Open AccessEinsamkeit am Lebensende
Zusammenfassung: Fortgeschrittene unheilbare Erkrankungen gehen aufgrund des zunehmenden Krankheitsprogresses mit zahlreichen Verlusten und Belastungen einher, welche die Autonomie und Selbstbestimmung sowie das Würdegefühl der Betroffenen erheblich beeinträchtigen und Einsamkeitsgefühle fördern können. Der gesundheitliche Abbau, die zunehmende Symptomlast, der Verlust von sozialen Rollen sowie die Angst vor dem Tod und dem Sterben zählen zu den wichtigsten Risikofaktoren für Einsamkeit am Lebensende. Dieser Artikel bietet einen Überblick über die verschiedenen Dimensionen der Einsamkeit am Lebensende. Die existentielle Einsamkeit wird in Abgrenzung zur emotionalen und sozialen Einsamkeit am Lebensende beleuchtet, Ursachen und gesundheitliche Auswirkungen von Einsamkeit am Lebensende werden diskutiert, auf diagnostische Instrumente wird hingewiesen und Empfehlungen zum Umgang mit der emotionalen, sozialen und existentiellen Einsamkeit am Lebensende werden ausgesprochen. Auch die Einsamkeit pflegender Angehöriger wird thematisiert. Im Artikel weisen wir darauf hin, wie wichtig es ist, der emotionalen und sozialen Einsamkeit am Lebensende frühzeitig entgegenzuwirken. Palliative, psychologische und spirituelle Unterstützung können dabei helfen, zwischenmenschliche Beziehungen zu stärken, Sinn und Bedeutung zu fördern und die negativen Auswirkungen von Einsamkeitsgefühlen auf die Gesundheit und die Lebensqualität zu reduzieren. Im Gegensatz dazu wird die existentielle Einsamkeit als Ausdruck hoher emotionaler Reife betrachtet und kann als entwicklungsfördernde Erfahrung zu einer besseren Verortung des Selbst sowie zur Stärkung von Identität, Würde und Transzendenz am Lebensende beitragen.
- 1 July 2024
- Vol. 113 (6-7) , 160-168
[Can we learn to die?].
The topic of death and the dying is a crucial aspect of patient care, especially for individuals with terminal illnesses. However, discussions about death and dying are often avoided during patient interactions. In this article, our aim is to explore the reasons behind our fear of death and dying and to assess the importance of addressing these issues in shaping and cultivating relationships with our patients and in our personal lives. We argue that being open to impermanence is a valuable tool in our work with patients and their families and should be integrated into conversations with them. Furthermore, discussions about death and dying should play a central role in medical and nursing education as well as professional development.
- 1 July 2024
- Vol. 113 (6-7) , 160-168
[Can we learn to die?].
The topic of death and the dying is a crucial aspect of patient care, especially for individuals with terminal illnesses. However, discussions about death and dying are often avoided during patient interactions. In this article, our aim is to explore the reasons behind our fear of death and dying and to assess the importance of addressing these issues in shaping and cultivating relationships with our patients and in our personal lives. We argue that being open to impermanence is a valuable tool in our work with patients and their families and should be integrated into conversations with them. Furthermore, discussions about death and dying should play a central role in medical and nursing education as well as professional development.
- Top Cited PapersOpen Access
- 14 March 2024
- Published by Springer Nature in BMC Palliative Care
- Vol. 23 (1) , 1-15
Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers – a randomized controlled study
Background: This study extended the original Dignity Therapy (DT) intervention by including partners and family caregivers (FCs) of terminally-ill cancer patients with the overall aim of evaluating whether DT can mitigate distress in both patients nearing the end of life and their FCs. Methods: In this multicenter, randomized controlled trial (RCT), a total of 68 patients with life expectancy < 6 months and clinically-relevant stress levels (Hospital Anxiety Depression total score; HADStot ≥ 8) including their FCs were randomly assigned to DT, DT + (including their FCs), or standard palliative care (SPC) in a 1:1:1 ratio. Study participants were asked to complete a set of questionnaires pre- and post-intervention. Results: The coalesced group (DT and DT +) revealed a significant increase in patients’ perceived quality of life (FACIT-Pal-14) following the intervention (mean difference 6.15, SD = 1.86, p < 0.01). We found a statistically significant group-by-time interaction effect: while the HADStot of patients in the intervention group remained stable over the pre-post period, the control group’s HADStot increased (F = 4.33, df = 1, 82.9; p < 0.05), indicating a protective effect of DT. Most patients and their FCs found DT useful and would recommend it to other individuals in their situation. Conclusions: The DT intervention has been well-received and shows the potential to increase HRQoL and prevent further mental health deterioration, illness burden and suffering in terminally-ill patients. The DT intervention holds the potential to serve as a valuable tool for facilitating end-of-life conversations among terminally-ill patients and their FCs. However, the implementation of DT within the framework of a RCT in a palliative care setting poses significant challenges. We suggest a slightly modified and less resource-intensive version of DT that is to provide the DT inventory to FCs of terminally-ill patients, empowering them to ask the questions that matter most to them over their loved one’s final days. Trial registration: This study was registered with Clinical Trial Registry (ClinicalTrials.gov -Protocol Record NCT02646527; date of registration: 04/01/2016). The CONSORT 2010 guidelines were used for properly reporting how the randomized trial was conducted.
- 14 March 2024
- Published by Springer Nature in BMC Palliative Care
- Vol. 23 (1) , 1-15
Top Cited PapersOpen AccessEffects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers – a randomized controlled study
Background: This study extended the original Dignity Therapy (DT) intervention by including partners and family caregivers (FCs) of terminally-ill cancer patients with the overall aim of evaluating whether DT can mitigate distress in both patients nearing the end of life and their FCs. Methods: In this multicenter, randomized controlled trial (RCT), a total of 68 patients with life expectancy < 6 months and clinically-relevant stress levels (Hospital Anxiety Depression total score; HADStot ≥ 8) including their FCs were randomly assigned to DT, DT + (including their FCs), or standard palliative care (SPC) in a 1:1:1 ratio. Study participants were asked to complete a set of questionnaires pre- and post-intervention. Results: The coalesced group (DT and DT +) revealed a significant increase in patients’ perceived quality of life (FACIT-Pal-14) following the intervention (mean difference 6.15, SD = 1.86, p < 0.01). We found a statistically significant group-by-time interaction effect: while the HADStot of patients in the intervention group remained stable over the pre-post period, the control group’s HADStot increased (F = 4.33, df = 1, 82.9; p < 0.05), indicating a protective effect of DT. Most patients and their FCs found DT useful and would recommend it to other individuals in their situation. Conclusions: The DT intervention has been well-received and shows the potential to increase HRQoL and prevent further mental health deterioration, illness burden and suffering in terminally-ill patients. The DT intervention holds the potential to serve as a valuable tool for facilitating end-of-life conversations among terminally-ill patients and their FCs. However, the implementation of DT within the framework of a RCT in a palliative care setting poses significant challenges. We suggest a slightly modified and less resource-intensive version of DT that is to provide the DT inventory to FCs of terminally-ill patients, empowering them to ask the questions that matter most to them over their loved one’s final days. Trial registration: This study was registered with Clinical Trial Registry (ClinicalTrials.gov -Protocol Record NCT02646527; date of registration: 04/01/2016). The CONSORT 2010 guidelines were used for properly reporting how the randomized trial was conducted.
- Open Access
- 2 February 2024
- Published by Elsevier in Comprehensive Psychoneuroendocrinology
- Vol. 17, 100226
The Psychoneuroimmunological Model of Moral Distress and Health in Healthcare Workers: Toward Individual and System-Level Solutions
- 2 February 2024
- Published by Elsevier in Comprehensive Psychoneuroendocrinology
- Vol. 17, 100226
Open AccessThe Psychoneuroimmunological Model of Moral Distress and Health in Healthcare Workers: Toward Individual and System-Level Solutions
- 1 April 2023
- Published by Hogrefe Publishing Group in Praxis
- Vol. 112 (5-6) , 297-303
Traum- und Wachvisionen am Lebensende
Zusammenfassung: Traum- und Wachvisionen am Lebensende (TWVL) sind Transzendenzerfahrungen, die als visuelle, akustische oder sensorische Qualität wahrgenommen werden und häufig die Erscheinung von Angehörigen oder Freunden ebenso wie Wahrnehmungen von schönen Orten, Reisen, Lichterscheinungen oder Klängen beinhalten können. Diese Phänomene treten typischerweise Wochen bis Stunden vor dem Tod auf und werden überwiegend als tröstlich beschrieben. Obwohl Traum- und Wachvisionen am Lebensende häufig vorkommen – ca. 30–80% der Sterbenden berichten von visionärem Erleben am Lebensende – wird diesem Phänomen in der Medizin kaum Bedeutung zugeschrieben und häufig als pathologische Veränderung im Rahmen eines Delirs behandelt. Dieser Artikel versucht anhand der Literatur sowie klinischer Beobachtungen die Abgrenzung zwischen Delir, Traum und TWVL zu illustrieren und die therapeutische Relevanz dieser Phänomene in der Begleitung von sterbenden Menschen und ihren Angehörigen aufzuzeigen.
- 1 April 2023
- Published by Hogrefe Publishing Group in Praxis
- Vol. 112 (5-6) , 297-303
Traum- und Wachvisionen am Lebensende
Zusammenfassung: Traum- und Wachvisionen am Lebensende (TWVL) sind Transzendenzerfahrungen, die als visuelle, akustische oder sensorische Qualität wahrgenommen werden und häufig die Erscheinung von Angehörigen oder Freunden ebenso wie Wahrnehmungen von schönen Orten, Reisen, Lichterscheinungen oder Klängen beinhalten können. Diese Phänomene treten typischerweise Wochen bis Stunden vor dem Tod auf und werden überwiegend als tröstlich beschrieben. Obwohl Traum- und Wachvisionen am Lebensende häufig vorkommen – ca. 30–80% der Sterbenden berichten von visionärem Erleben am Lebensende – wird diesem Phänomen in der Medizin kaum Bedeutung zugeschrieben und häufig als pathologische Veränderung im Rahmen eines Delirs behandelt. Dieser Artikel versucht anhand der Literatur sowie klinischer Beobachtungen die Abgrenzung zwischen Delir, Traum und TWVL zu illustrieren und die therapeutische Relevanz dieser Phänomene in der Begleitung von sterbenden Menschen und ihren Angehörigen aufzuzeigen.
- 1 November 2021
- Published by Hogrefe Publishing Group in Praxis
- Vol. 110 (15) , 872-878
Delirmanagement in der Palliative Care
Zusammenfassung. Delir ist eine der häufigsten neuropsychiatrischen Komplikationen bei Personen mit einer fortgeschrittenen unheilbaren Erkrankung. Delir am Lebensende tritt häufig auf, wird aber oft übersehen, nicht diagnostiziert oder falsch/nicht behandelt. Delirien sind auch bei palliativer Situation – so weit möglich – zu behandeln, weil persistierende delirante Zustände die Fragilität der Patientinnen und Patienten erhöhen, die körperliche Funktionalität einschränken und die Lebenszeit verkürzen. Zudem lösen akute Verwirrtheitszustände hohen Distress bei Betroffenen und deren Angehörigen aus, beeinträchtigen die Lebensqualität und verhindern ein würdevolles Sterben. Während Halluzinationen und Visionen am Lebensende in der Medizin als Delirium interpretiert und als solches behandelt werden, wird dieses Phänomen von der philosophischen und theologischen Hermeneutik als eine Ressource interpretiert, die den Betroffenen und deren Angehörigen helfen kann, sich mit vergangenen Lebensereignissen zu versöhnen und sich mit dem Sterbeprozess auseinanderzusetzen. Das Auftreten von Visionen am Lebensende in Abgrenzung zum Delir ist jedoch noch wenig untersucht und bedarf einer genaueren Exploration.
- 1 November 2021
- Published by Hogrefe Publishing Group in Praxis
- Vol. 110 (15) , 872-878
Delirmanagement in der Palliative Care
Zusammenfassung. Delir ist eine der häufigsten neuropsychiatrischen Komplikationen bei Personen mit einer fortgeschrittenen unheilbaren Erkrankung. Delir am Lebensende tritt häufig auf, wird aber oft übersehen, nicht diagnostiziert oder falsch/nicht behandelt. Delirien sind auch bei palliativer Situation – so weit möglich – zu behandeln, weil persistierende delirante Zustände die Fragilität der Patientinnen und Patienten erhöhen, die körperliche Funktionalität einschränken und die Lebenszeit verkürzen. Zudem lösen akute Verwirrtheitszustände hohen Distress bei Betroffenen und deren Angehörigen aus, beeinträchtigen die Lebensqualität und verhindern ein würdevolles Sterben. Während Halluzinationen und Visionen am Lebensende in der Medizin als Delirium interpretiert und als solches behandelt werden, wird dieses Phänomen von der philosophischen und theologischen Hermeneutik als eine Ressource interpretiert, die den Betroffenen und deren Angehörigen helfen kann, sich mit vergangenen Lebensereignissen zu versöhnen und sich mit dem Sterbeprozess auseinanderzusetzen. Das Auftreten von Visionen am Lebensende in Abgrenzung zum Delir ist jedoch noch wenig untersucht und bedarf einer genaueren Exploration.
- Open Access
- 12 April 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (4) , 455
The Actualization of the Transplantation Complex on the Axis of Psychosomatic Totality—Results of a Qualitative Study
Although transplantation medicine is not new, there is a clinically justified gap in the existing literature with respect to the psychological processing of lung transplants. The present study aims to examine whether lung transplantation leads to an actualization of psychological, e.g., oral-sadistic fantasies. Following a qualitative approach, 38 lung transplant patients were interviewed three times within the first six months after transplantation. Data analysis focused on identifying unconscious and conscious material. The inter-rater reliability for all codes was calculated using Krippendorff’s Alpha (c-α-binary = 0.94). Direct and implicit evidence of a so-called transplantation complex was detected e.g., regarding the “incorporation” of the dead donor and his lungs. These processes occur predominantly at an imaginary level and are related to the body. Our findings emphasize that such psychological aspects should be borne in mind in the psychological treatment of lung-transplant patients in order to improve the processing of lung transplants, and that this might have a positive effect on patient adherence.
- 12 April 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (4) , 455
Open AccessThe Actualization of the Transplantation Complex on the Axis of Psychosomatic Totality—Results of a Qualitative Study
Although transplantation medicine is not new, there is a clinically justified gap in the existing literature with respect to the psychological processing of lung transplants. The present study aims to examine whether lung transplantation leads to an actualization of psychological, e.g., oral-sadistic fantasies. Following a qualitative approach, 38 lung transplant patients were interviewed three times within the first six months after transplantation. Data analysis focused on identifying unconscious and conscious material. The inter-rater reliability for all codes was calculated using Krippendorff’s Alpha (c-α-binary = 0.94). Direct and implicit evidence of a so-called transplantation complex was detected e.g., regarding the “incorporation” of the dead donor and his lungs. These processes occur predominantly at an imaginary level and are related to the body. Our findings emphasize that such psychological aspects should be borne in mind in the psychological treatment of lung-transplant patients in order to improve the processing of lung transplants, and that this might have a positive effect on patient adherence.
- Open Access
- 12 January 2021
- Published by Cambridge University Press (CUP) in Palliative and Supportive Care
- Vol. 19 (3) , 294-303
Delirium is associated with an increased morbidity and in-hospital mortality in cancer patients: Results from a prospective cohort study
Objective: Delirium is a frequent complication in advanced cancer patients, among whom it is frequently underdiagnosed and inadequately treated. To date, evidence on risk factors and the prognostic impact of delirium on outcomes remains sparse in this patient population.Method: In this prospective observational cohort study at a single tertiary-care center, 1,350 cancer patients were enrolled. Simple and multiple logistic regression models were utilized to identify associations between predisposing and precipitating factors and delirium. Cox proportional-hazards models were used to estimate the effect of delirium on death rate.Results: In our patient cohort, the prevalence of delirium was 34.3%. Delirium was associated inter alia with prolonged hospitalization, a doubling of care requirements, increased healthcare costs, increased need for institutionalization (OR 3.22), and increased mortality (OR 8.78). Predisposing factors for delirium were impaired activity (OR 10.82), frailty (OR 4.75); hearing (OR 2.23) and visual impairment (OR 1.89), chronic pneumonitis (OR 2.62), hypertension (OR 1.46), and renal insufficiency (OR 1.82). Precipitating factors were acute renal failure (OR 7.50), pressure sores (OR 3.78), pain (OR 2.86), and cystitis (OR 1.32). On multivariate Cox regression, delirium increased the mortality risk sixfold (HR 5.66). Age ≥ 65 years and comorbidities further doubled the mortality risk of delirious patients (HR 1.77; HR 2.05).Significance of results: Delirium is common in cancer patients and associated with increased morbidity and mortality. Systematically categorizing predisposing and precipitating factors might yield new strategies for preventing and managing delirium in cancer patients.
- 12 January 2021
- Published by Cambridge University Press (CUP) in Palliative and Supportive Care
- Vol. 19 (3) , 294-303
Open AccessDelirium is associated with an increased morbidity and in-hospital mortality in cancer patients: Results from a prospective cohort study
Objective: Delirium is a frequent complication in advanced cancer patients, among whom it is frequently underdiagnosed and inadequately treated. To date, evidence on risk factors and the prognostic impact of delirium on outcomes remains sparse in this patient population.Method: In this prospective observational cohort study at a single tertiary-care center, 1,350 cancer patients were enrolled. Simple and multiple logistic regression models were utilized to identify associations between predisposing and precipitating factors and delirium. Cox proportional-hazards models were used to estimate the effect of delirium on death rate.Results: In our patient cohort, the prevalence of delirium was 34.3%. Delirium was associated inter alia with prolonged hospitalization, a doubling of care requirements, increased healthcare costs, increased need for institutionalization (OR 3.22), and increased mortality (OR 8.78). Predisposing factors for delirium were impaired activity (OR 10.82), frailty (OR 4.75); hearing (OR 2.23) and visual impairment (OR 1.89), chronic pneumonitis (OR 2.62), hypertension (OR 1.46), and renal insufficiency (OR 1.82). Precipitating factors were acute renal failure (OR 7.50), pressure sores (OR 3.78), pain (OR 2.86), and cystitis (OR 1.32). On multivariate Cox regression, delirium increased the mortality risk sixfold (HR 5.66). Age ≥ 65 years and comorbidities further doubled the mortality risk of delirious patients (HR 1.77; HR 2.05).Significance of results: Delirium is common in cancer patients and associated with increased morbidity and mortality. Systematically categorizing predisposing and precipitating factors might yield new strategies for preventing and managing delirium in cancer patients.